These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of uncomplicated skin and skin structure infections in the diabetic patient. Rich P J Drugs Dermatol; 2005; 4(6 Suppl):s26-9. PubMed ID: 16300227 [TBL] [Abstract][Full Text] [Related]
4. Update on the treatment of diabetic foot infections. Kosinski MA; Joseph WS Clin Podiatr Med Surg; 2007 Jul; 24(3):383-96, vii. PubMed ID: 17613382 [TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers]. Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242 [TBL] [Abstract][Full Text] [Related]
6. [Antibiotic therapy in elderly patients]. Bellmann-Weiler R; Weiss G Dtsch Med Wochenschr; 2008 Feb; 133(8):350-3. PubMed ID: 18270915 [No Abstract] [Full Text] [Related]
7. Wound care for salvaging diabetic foot. Cabeza de Vaca FG; Macias AE J Hosp Infect; 2008 Dec; 70(4):386-7; author reply 385-6. PubMed ID: 18951665 [No Abstract] [Full Text] [Related]
8. Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. Fejfarová V; Jirkovská A; Petkov V; Boucek P; Skibová J J Diabetes Complications; 2004; 18(2):108-12. PubMed ID: 15120705 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Bradford PA; Weaver-Sands DT; Petersen PJ Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic choices in the infected diabetic foot/ulcer. Waspadji S Acta Med Indones; 2005; 37(2):94-101. PubMed ID: 15925854 [No Abstract] [Full Text] [Related]
11. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792 [TBL] [Abstract][Full Text] [Related]
12. Treatment of polymicrobial intra-abdominal, pelvic, and diabetic foot infections. Zervos M Compr Ther; 1998; 24(6-7):295-301. PubMed ID: 9669093 [TBL] [Abstract][Full Text] [Related]
13. [Selection of empirical antibiotic therapy in skin infections with complications]. Chosidow O Med Mal Infect; 2011 Jan; 41(1 Suppl 1):H4-5. PubMed ID: 21335252 [No Abstract] [Full Text] [Related]
14. Isolation of Salmonella paratyphi A from a female with diabetic foot ulcer. Chander J; Gupta V; Sidhu S; Sharma R Indian J Pathol Microbiol; 2011; 54(2):427-8. PubMed ID: 21623125 [No Abstract] [Full Text] [Related]
15. Isolation of Enterococcus species from infectious skin lesions. Higaki S; Morohashi M; Yamagishi T Drugs Exp Clin Res; 2002; 28(2-3):91-3. PubMed ID: 12224382 [TBL] [Abstract][Full Text] [Related]
16. [Consensus document on the antimicrobial treatment of diabetic-foot infections]. ; ; ; Rev Esp Quimioter; 2007 Mar; 20(1):77-92. PubMed ID: 17530039 [No Abstract] [Full Text] [Related]
17. Skin and soft tissue infection: frequency of aerobic bacterial isolates and their antimicrobial susceptibility pattern. Gupta V; Datta P; Singla N J Assoc Physicians India; 2008 May; 56():389-90. PubMed ID: 18700650 [No Abstract] [Full Text] [Related]
18. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP; Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297 [TBL] [Abstract][Full Text] [Related]